Sustained inhibitory effect of Agouti Related Protein on the ACTH-induced cortisol production by bovine cultured adrenal cells.
Doghman. Mabrouka M; Delagrange. Philippe P; Berthelon. Marie-Claude MC; Durand. Philippe P; Naville. Danielle D; Bégeot. Martine M
Key Findings
- AGRP dose‑dependently inhibits cortisol release triggered by both NDP‑alphaMSH and ACTH in bovine adrenal cells
- The inhibition shows a U‑shaped curve: low AGRP concentrations are more effective than higher ones
- The ACTH‑related inhibition isn’t due to blocking the MC2‑R or MC4‑R receptors, implying an unknown mechanism
Practical Outcomes
- For biohackers, the results suggest that targeting AGRP could influence cortisol levels, but the study offers no clear, safe protocol for humans or for using melanotan‑I. It’s mainly a mechanistic insight with limited immediate application.
Summary
A study in cow adrenal cells found that a protein called Agouti‑Related Protein (AGRP) can lower cortisol (the stress hormone) released after stimulation, but it works in a weird way that isn’t through the usual receptors, and the effect is strongest at low doses and fades at higher ones. This doesn’t directly tell you how to use melanotan‑I or other peptides for health hacks.
Abstract
The adrenal gland is the second tissue after hypothalamus exhibiting high expression level of Agouti Related Protein (Agrp) mRNA, which suggests that this peptide may control adrenal cell functions. However, its role in this tissue remained to be determined. In this report, we studied the effects of a long-term treatment (24 h) of cultured bovine adrenal cells by Agrp on the (Nle4, d-Phe7)-alphaMSH (NDP-alphaMSH)- or ACTH-induced cortisol release. We showed that Agrp inhibited, in a dose-dependent manner, the 10(-9) M NDP-alphaMSH-induced cortisol production through its antagonistic properties towards MSH at the level of MC4-R. Surprisingly, we found that Agrp in the same conditions of cell treatment also induced a strong inhibition of the ACTH-induced cortisol release. These effects were stronger using low concentrations of Agrp and disappeared for higher concentrations resulting in U-shaped curve data. There was no effect of SHU9119 in the same conditions of stimulation of the cells. Our data confirmed that Agrp is not an antagonist of ACTH at the level of MC2-R and that its sustained effect on ACTH-induced steroidogenesis did not involve its antagonistic properties at the level of MC4-R. The hypothesis would be that Agrp is acting on adrenal steroidogenesis through an alternate mechanism.
Study Information
pubmed
2005
2005-01-15T00:00:00.000Z
10.1016/j.regpep.2004.07.020
11
18